Research Topic · Peer-Reviewed

Cerebral Blood Flow Assay

Cerebral Blood Flow (CBF) is a critical indicator of brain health, pathology, and therapy response. Cerebral Blood Flow Assay refers to the measurement of CBF in neurological research and therapy. Cerebral Blood Flow Assay is significant in evaluating the causes and consequences of different neurological disorders, …

Curated from this journal's research 📚 5 peer-reviewed articles cited Cited 11× across the literature 🔖 ISSN 2470-5020 🗓 Reviewed June 2026

Overview

Cerebral Blood Flow (CBF) is a critical indicator of brain health, pathology, and therapy response. Cerebral Blood Flow Assay refers to the measurement of CBF in neurological research and therapy. Cerebral Blood Flow Assay is significant in evaluating the causes and consequences of different neurological disorders, including stroke, Alzheimer’s disease, and traumatic brain injury. Additionally, CBF Assay is helpful in monitoring the progression of a neurological disease and confirming the effectiveness of a therapeutic intervention. The primary method for measuring CBF is through Imaging techniques such as Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) scanning. These widely used techniques provide information on the amount of blood that flows, and consequently, the amount of oxygen delivered to the brain's tissue. However, there are limitations to these techniques, including the cost of the machinery, the need for specialized staff to operate, patient discomfort due to radiation exposure, and limited resolution. Recent advances in Neurological research have led to the development of new methods for measuring CBF that are inexpensive, non-invasive, and easy to use. These new techniques include Ultrasound, Thermal Diffusion, Near-Infrared Spectroscopy, and Laser Doppler Flowmetry, among others. These methods have the potential to improve diagnosis and treatment of neurological disorders in a clinical setting. In conclusion, Cerebral Blood Flow Assay is an essential tool in the evaluation of neurological disorders, monitoring progression and therapeutic interventions. Advancements in technology have improved the accuracy and accessibility of measuring CBF, with the potential for further innovation in the future. Researchers and clinicians must continue to explore and develop CBF Assay techniques to improve patient outcomes and advance neurological research.

Research published in this journal

5 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 5 articles above have been cited 11 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Cerebral Blood Flow Assay, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Neurological Research and Therapy (ISSN 2470-5020).

Journal editorial board
Ian J Martins · Australia Giuseppe Lanza · Italy Ion Codreanu · United States

This page summarises published research for orientation; it is not medical or professional advice.